Andrew Todd, MD
Orthopaedic Surgery of the Spine · New Orleans, LANPI 1104021526
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,700 of the $12,489 with a category attached, or 93.7%. Surgalign Spine Technologies, Inc. accounts for 94.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $11,700 and has fallen 99.2% since, to $91 in 2025.
Across 18 payments — averaging $693.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surgalign Spine Technologies, Inc.$12K
- Highridge Medical LLC$150
- Johnson & Johnson$147
- Nevro Corp.$99
- Sumitomo Pharma America, Inc.$89
- Stryker$75
- plus $179 from 6 others
What the payments were for
- Consulting fees$11,70094%
- Travel & lodging$500%
- Food & beverage$7396%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surgalign Spine Technologies, Inc. | 2 | $11,750 |
| Highridge Medical LLC | 1 | $150 |
| Johnson & Johnson | 2 | $147 |
| Nevro Corp. | 2 | $99 |
| Sumitomo Pharma America, Inc. | 3 | $89 |
| Stryker | 1 | $75 |
| Vericel Corporation | 2 | $44 |
| Acera Surgical, Inc. | 1 | $34 |
| Providence Medical Technology, Inc. | 1 | $31 |
| Medtronic | 1 | $26 |
| Bioventus LLC | 1 | $23 |
| Innovation Technologies Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FORTILINK-A$11,700
- The Tether$150
- EXPEDIUM$109
How this compares
$12,489 in reported general payments places this provider in the 55th percentile of 29 orthopaedic surgery of the spine providers in Louisiana.
See all orthopaedic surgery of the spine providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 239 | $2,373 |
| Gabapentin | 94 | $1,571 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 41 | $789 |
| Methylprednisolone | 49 | $373 |
| Methocarbamol | 68 | $330 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $298 |
| Ibuprofen | 14 | $270 |
| Cyclobenzaprine Hcl | 64 | $267 |
| Tramadol Hcl | 73 | $239 |
| Meloxicam | 59 | $197 |
| Pregabalin | 24 | $163 |
| Alendronate Sodium | 20 | $77 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in New Orleans
- Mathew CyriacNew Orleans$368K
- Charles YuNew Orleans$52K
- William AccoustiNew Orleans$46K
- Amit BhandutiaNew Orleans$39K
- Felipe Ramirez-TerrassaNew Orleans$15K
- Parth DesaiNew Orleans$6K
- Andrew KingNew Orleans$5K
- Caroline SchneiderNew Orleans$641
- Paul DimartinoNew Orleans$165
- Joseph ZavatskyMetairie$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.